Bernd Gansbacher
Overview
Explore the profile of Bernd Gansbacher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zavlin D, Jubbal K, Noe J, Gansbacher B
Ger Med Sci
. 2017 Oct;
15:Doc15.
PMID: 29051721
Both Germany and the United States of America have a long tradition of science and medical excellence reaching back as far as the nineteenth century. The same tribute must be...
2.
Boran T, Menezes-Ferreira M, Reischl I, Celis P, Ferry N, Gansbacher B, et al.
Hum Gene Ther Clin Dev
. 2017 May;
28(3):126-135.
PMID: 28510497
The research and development of advanced therapy medicinal products (ATMPs) has been active in Europe and worldwide during recent years. Yet, the number of licensed products remains low. The main...
3.
Anton M, Wolf A, Mykhaylyk O, Koch C, Gansbacher B, Plank C
Pharm Res
. 2011 Dec;
29(5):1219-31.
PMID: 22207207
Purpose: To target adenoviral vectors to cells of the vasculature and shielding vectors from inactivation by the immune system. Methods: Complexes of reporter gene expressing adenoviral vectors with positively charged...
4.
Holzmuller R, Mantwill K, Haczek C, Rognoni E, Anton M, Kasajima A, et al.
Int J Cancer
. 2011 Jun;
129(5):1265-76.
PMID: 21710499
The human Y-box binding protein 1 (YB-1) is known to be a promising target for cancer therapy. We have demonstrated that YB-1 plays an important role in the adenoviral life...
5.
6.
Wubbenhorst D, Dumler K, Wagner B, Wexel G, Imhoff A, Gansbacher B, et al.
Arthritis Rheum
. 2010 Mar;
62(7):2037-46.
PMID: 20309869
Objective: Treatment of cartilage defects is still challenging, primarily because of the poor self-healing capacity of articular cartilage. Gene therapy approaches have gained considerable attention, but, depending on the vector...
7.
Schrotzlmair F, Kopitz C, Halbgewachs B, Lu F, Algul H, Brunner N, et al.
J Cell Mol Med
. 2009 Oct;
14(12):2760-70.
PMID: 19863693
Paradoxically, not only proteinases but also their inhibitors can correlate with bad prognosis of cancer patients, underlining the evolving concept of the protease web as the complex interplay between proteinases,...
8.
9.
Tischer T, Aryee S, Wexel G, Steinhauser E, Adamczyk C, Eichhorn S, et al.
Tissue Eng Part A
. 2009 Oct;
16(3):1031-40.
PMID: 19845462
The acellularization of tendons using detergents (sodium dodecyl sulfate, Triton-X, tri-nitro-butyl-phosphate) is a new source of scaffolds for tissue engineering in anterior cruciate ligament (ACL) repair. In vitro testing demonstrated...
10.
Brill T, Kubler H, Pohla H, Buchner A, Fend F, Schuster T, et al.
Hum Gene Ther
. 2009 Aug;
20(12):1641-51.
PMID: 19671000
Immunotherapy with whole cell cancer vaccines has been tested in various tumor types. This study investigated the safety profile and antitumor activity of an allogeneic prostate carcinoma cell line, LNCaP,...